- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
SIGA Technologies Inc
+ Add to WatchlistSIGA:US
3.5800 USD 0.0200 0.56%As of 20:10:00 ET on 05/17/2013.
Snapshot for SIGA Technologies Inc (SIGA)
| Open: | 3.6300 | Day's Range: | 3.5000 - 3.6400 | Volume: | 148,148 |
|---|---|---|---|---|---|
| Previous Close: | 3.6000 | 52wk Range: | 2.2000 - 4.6000 | 1-Yr Rtn: | +50.42% |
Key Statistics for SIGA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 4.9930 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.2900 |
| Est. EPS (USD) (12/2013) | 0.7170 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 186.61 |
| Shares Outstanding (M) | 52.13 |
| 30 Day Average Volume | 185,725 |
| Price/Book (mrq) | 7.3178 |
| Price/Sale (ttm) | 20.9331 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SIGA
Company Profile & Key Executives for SIGA
SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company's also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.
| Eric A RoseChairman/CEO | Daniel J LuckshireExec VP/CFO/Secretary |
| Dennis E HrubyVP/Chief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SIGA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page